Wisconsin Department of Commerce Newsletter
Gov. Doyle Announces Funding for Further Expansion of Eragen Biosciences, Inc. Product Development Capabilities
Gov. Jim Doyle recently announced the EraGen Biosciences, Inc., Madison, Dane county, will receive a $250,000 Technology Development Loan (TDL) program to upgrade its manufacturing facility.
"Through my Grow Wisconsin plan, we are working hard to invest in our economy and help technology companies upgrade and innovate," Governor Doyle said. "I am pleased that the state can help EraGen Biosciences, Inc. invest in its business and remain at the forefront of genetic testing technology."
"We are off to a great start in 2005 and have a number of exciting business opportunities in progress which I anticipate will put us in a powerful position in the molecular diagnostics market in 2006." said Dr. Irene Hrusovsky, President and CEO of EraGen Biosciences. "Our continued work with Wisconsin diagnostics leaders broadens our product portfolio in both genetic and infectious disease testing. An innovative test was developed at The Blood Center of Southeastern Wisconsin, in collaboration with the research and development team at EraGen for a new comprehensive platelet antigen test.
"Projects are also underway at the University of Wisconsin to include a test for multiple respiratory viruses. These collaborations, in addition with the recently announced agreement with Bayer Healthcare, enhance our reputation for developing fast and effective molecular diagnostic products. The support from Governor Doyle and the Department of Commerce has made a significant contribution to growing our business both in the State and globally."
EraGen Biosciences, Inc. develops and markets nucleic acid diagnostic technologies. The company is investing $1.0 million to upgrade its manufacturing capacity to produce its CF assay under good manufacturing practices.
Based in Madison, EraGen Biosciences, Inc. is driving innovative molecular diagnostics and drugs to market faster. The company develops and commercializes high performance automated molecular diagnostics and drug discovery products to serve the rapidly growing market for personalized medicine and rapid response needs for bioterrorism. Further information is available at www.eragen.com, or 608-662-9000.
The TDL program assists Wisconsin businesses that have developed technological innovations and have the potential to provide significant economic benefit to the state. This program is designed to assist the business in bringing the new technology to commercialization.
For more information about the Technology Development Loan (TDL) program, contact John Stricker at 608/261-7710.
-- Tony Hozeny
The newsletter is issued electronically every other month.
Please send comments or questions to Barbro McGinn, editor.